Martin Shkreli's Age: How Old Is The Pharma Bro?

Martin Shkreli is a name that has been synonymous with controversy. Best known for his role in inflating the price of the life-saving drug Daraprim, Shkreli, often dubbed "Pharma Bro," has attracted considerable notoriety.

So, how old is Martin Shkreli?

As of November 2024, Martin Shkreli is 41 years old. He was born on March 17, 1983.

Early Life and Education

Born in Brooklyn, New York, to Albanian and Croatian immigrants, Shkreli demonstrated an early aptitude for business and finance. He attended Hunter College, graduating with a degree in business administration.

Career Beginnings

Shkreli's career began on Wall Street, where he worked for various hedge funds. His early ventures set the stage for his later, more controversial endeavors in the pharmaceutical industry.

Pharmaceutical Controversies

Shkreli founded Turing Pharmaceuticals, later renamed Vyera Pharmaceuticals. It was his decision to increase the price of Daraprim by over 5,000% that sparked widespread outrage. Daraprim is a drug used to treat toxoplasmosis, a condition that affects people with weakened immune systems, including those with HIV/AIDS.

The price hike from $13.50 to $750 per pill made Shkreli a symbol of corporate greed and unethical business practices. The controversy led to numerous investigations and widespread condemnation from the public and healthcare professionals.

Legal Troubles and Conviction

In addition to the Daraprim controversy, Shkreli faced legal troubles related to his management of hedge funds and Retrophin, another pharmaceutical company he founded. He was convicted of securities fraud in 2017 and sentenced to seven years in prison.

Imprisonment and Release

Shkreli served part of his sentence before being released early in May 2022, due to good behavior and time served. His release did not mark the end of his public presence, as he quickly returned to social media and the public eye, often sharing his views on finance, pharmaceuticals, and other topics.

Post-Release Activities

Since his release, Shkreli has remained active in the business world, particularly in the cryptocurrency and technology sectors. He has also been involved in various online discussions and continues to provoke reactions with his commentary.

Continuing Influence

Despite his past controversies, Shkreli remains a figure of interest. His story serves as a cautionary tale about the ethical responsibilities of pharmaceutical companies and the potential consequences of prioritizing profit over patient welfare.

Conclusion

Martin Shkreli's age, 41 as of November 2024, is just one facet of a complex and controversial persona. From his early days in finance to his infamous role in the pharmaceutical industry, Shkreli's actions have left an indelible mark on the healthcare landscape. Whether he can rehabilitate his image remains to be seen, but his legacy as the "Pharma Bro" is firmly entrenched in public memory.